Celularity Inc. Class A Common Stock (CELU)
NASDAQ
0.9780
-0.07 (-6.86%)
Closed
Oct 23, 2026
Day's Range
0.91101.14
52 wk Range
0.56002.55
Financial Statements - CELU - Celularity Inc. Class A Common Stock
Revenue
26.55M▼ 51.0%
Net Income
-91.71M▼ 58.4%Net Margin -345.4%
EBITDA
-65.16M▼ 61.3%
Free Cash Flow
-13.25M▼ 102.0%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 26.55M | 54.22M | 22.77M | 17.97M | 21.33M | 14.27M |
| Cost of Goods | 20.07M | 14.98M | 16.01M | 19.66M | 9.65M | 4.93M |
| Gross Profit | 6.47M | 39.23M | 6.75M | -1.69M | 11.68M | 9.34M |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | -61.30M | -38.55M | -76.47M | -148.26M | -150.20M | -78.09M |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | -23.91M | -13.40M | -117.11M | 162.10M | 52.94M | -132.85M |
| Pre Tax Income | -91.71M | -57.89M | -196.28M | 14.20M | -100.09M | -212.93M |
| Income Tax | 3K | 0 | 10K | 13K | 20K | -4.70M |
| Net Income | -91.71M | -57.89M | -196.29M | 14.19M | -100.11M | -208.23M |
| EPS Basic | - | -2.64 | -110.2 | 1.01 | -14.9 | -17.000393 |
| EPS Diluted | - | -2.64 | -110.2 | 0.95 | -14.9 | -17.000393 |
| Basic Shares Outstanding | - | 21.89M | 1.78M | 13.99M | 6.70M | 12.24M |
| Diluted Shares Outstanding | - | 21.89M | 1.78M | 13.99M | 6.70M | 12.24M |
| Ebit | -84.95M | -51.62M | -193.27M | 14.20M | -96.92M | -210.57M |
| Ebitda | -65.16M | -40.38M | -74.30M | -141.13M | -142.73M | -65.45M |
| Net Income Continuous Operations | -91.71M | -57.89M | -196.29M | 14.19M | -100.11M | -208.23M |
| Minority Interests | - | - | - | - | - | - |
| Preferred Stock Dividends | 64K | - | - | - | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
